Capital Investment Advisors, LLC Bristol Myers Squibb CO Transaction History

Capital Investment Advisors, LLC

  • $4.79 Billion
  • Q3 2024

A detailed history of Capital Investment Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Capital Investment Advisors, LLC holds 259,514 shares of BMY stock, worth $15.2 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares
259,514
Previous 260,740 0.47%
Holding current value
$15.2 Million
Previous $10.8 Million 24.02%
% of portfolio
0.28%
Previous 0.25%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024
SELL
$39.66 - $51.75 $48,623 - $63,445
-1,226 Reduced 0.47%
259,514 $13.4 Million
Q2 2024

Jul 12, 2024
SELL
$40.25 - $52.99 $512,664 - $674,933
-12,737 Reduced 4.66%
260,740 $10.8 Million
Q1 2024

Apr 15, 2024
BUY
$47.98 - $54.4 $466,413 - $528,822
9,721 Added 3.69%
273,477 $14.8 Million
Q4 2023

Jan 05, 2024
SELL
$48.48 - $57.85 $877,003 - $1.05 Million
-18,090 Reduced 6.42%
263,756 $13.5 Million
Q3 2023

Oct 16, 2023
BUY
$57.89 - $64.73 $441,642 - $493,825
7,629 Added 2.78%
281,846 $16.4 Million
Q2 2023

Jul 11, 2023
BUY
$63.71 - $70.74 $299,118 - $332,124
4,695 Added 1.74%
274,217 $17.5 Million
Q1 2023

Apr 10, 2023
BUY
$65.71 - $74.53 $627,793 - $712,059
9,554 Added 3.68%
269,522 $18.7 Million
Q4 2022

Jan 05, 2023
BUY
$68.48 - $81.09 $958,446 - $1.13 Million
13,996 Added 5.69%
259,968 $18.7 Million
Q3 2022

Oct 05, 2022
BUY
$0.13 - $76.84 $1,597 - $944,056
12,286 Added 5.26%
245,972 $17.5 Million
Q2 2022

Jul 06, 2022
BUY
$72.62 - $79.98 $664,545 - $731,896
9,151 Added 4.08%
233,686 $18 Million
Q1 2022

Apr 13, 2022
BUY
$61.48 - $73.72 $528,482 - $633,697
8,596 Added 3.98%
224,535 $16.4 Million
Q4 2021

Jan 10, 2022
BUY
$53.63 - $62.52 $357,175 - $416,383
6,660 Added 3.18%
215,939 $13.5 Million
Q3 2021

Oct 13, 2021
BUY
$59.17 - $69.31 $1.45 Million - $1.7 Million
24,507 Added 13.26%
209,279 $12.4 Million
Q2 2021

Jul 14, 2021
BUY
$61.91 - $67.42 $860,487 - $937,070
13,899 Added 8.13%
184,772 $12.3 Million
Q1 2021

Apr 27, 2021
BUY
$59.34 - $66.74 $1.45 Million - $1.63 Million
24,426 Added 16.68%
170,873 $10.8 Million
Q4 2020

Jan 21, 2021
BUY
$57.74 - $65.43 $1.74 Million - $1.97 Million
30,136 Added 25.91%
146,447 $9.08 Million
Q3 2020

Oct 29, 2020
BUY
$57.43 - $63.64 $405,168 - $448,980
7,055 Added 6.46%
116,311 $7.01 Million
Q2 2020

Jul 20, 2020
BUY
$54.82 - $64.09 $692,266 - $809,328
12,628 Added 13.07%
109,256 $6.42 Million
Q1 2020

Apr 13, 2020
BUY
$46.4 - $67.43 $52,896 - $76,870
1,140 Added 1.19%
96,628 $5.39 Million
Q4 2019

Jan 21, 2020
SELL
$49.21 - $64.19 $93,351 - $121,768
-1,897 Reduced 1.95%
95,488 $6.13 Million
Q3 2019

Oct 24, 2019
BUY
$42.77 - $50.71 $297,508 - $352,738
6,956 Added 7.69%
97,385 $4.94 Million
Q2 2019

Jul 17, 2019
BUY
$44.62 - $49.34 $982,309 - $1.09 Million
22,015 Added 32.18%
90,429 $4.1 Million
Q1 2019

Apr 11, 2019
BUY
$45.12 - $53.8 $615,211 - $733,563
13,635 Added 24.89%
68,414 $3.26 Million
Q4 2018

Jan 17, 2019
BUY
$48.76 - $63.23 $491,988 - $637,990
10,090 Added 22.58%
54,779 $2.85 Million
Q3 2018

Oct 15, 2018
SELL
$55.19 - $62.25 $17,495 - $19,733
-317 Reduced 0.7%
44,689 $2.77 Million
Q2 2018

Jul 10, 2018
BUY
$50.53 - $62.98 $24,052 - $29,978
476 Added 1.07%
45,006 $2.49 Million
Q1 2018

Apr 16, 2018
SELL
$59.92 - $68.98 $37,210 - $42,836
-621 Reduced 1.38%
44,530 $2.82 Million
Q4 2017

Jan 17, 2018
SELL
$59.94 - $65.35 $30,209 - $32,936
-504 Reduced 1.1%
45,151 $2.77 Million
Q3 2017

Oct 17, 2017
BUY
$55.23 - $63.74 $2.52 Million - $2.91 Million
45,655
45,655 $2.91 Million

Others Institutions Holding BMY

# of Institutions
2,536
Shares Held
1.47B
Call Options Held
31.6M
Put Options Held
35M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Capital Investment Advisors, LLC Portfolio

Follow Capital Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Investment Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email